BK-FLU Phase II Study in healthy Adults clinical trial

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222459

Enrollment

Registered

2014-04-15

Start date

2014-04-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza prevention

Interventions

investigational material(s) Generic name etc : BK-FLU INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : Subcutaneousl

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy Japanese adult

Exclusion criteria

Exclusion criteria: Subjects with history of influenza within 6 months Subjects with history of influenza vaccination within 6 months

Design outcomes

Primary

Measure	Time frame
Safety	—

Secondary

Measure	Time frame
Immunogenicity	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026